Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EU.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.273NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.13 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.358NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.159NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.625NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HH.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.332NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.86.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JW.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.21.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ES.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.19.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.479NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.437NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.148NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used